Optimization of the monocyte activation test for evaluating pyrogenicity of tick-borne encephalitis virus vaccine

Autor: Etna MP; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Giacomini E; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Rizzo F; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Severa M; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Ricci D; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Shaid S; GSK, Wavre, Belgium., Lambrigts D; GSK, Wavre, Belgium., Valentini S; GSK, Siena, Italy., Galli Stampino L; GSK, Siena, Italy., Alleri L; GSK, Siena, Italy., Gaggioli A; National Center for Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy., Von Hunolstein C; National Center for Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, Italy., Spreitzer I; Paul Ehrlich Institute, Federal Agency for Sera and Vaccines, Langen, Germany., Coccia EM; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Publikováno v: ALTEX [ALTEX] 2020; Vol. 37 (4), pp. 532-544. Date of Electronic Publication: 2020 May 26.

Effect of B cell/plasma cell depletion or suppression on Anti-Gal antibody in the baboon

Autor: Basker, M, Alwayn, I.P.J, Treter, S, Harper, D, Buhler, L, Andrews, D, Thall, A, Lambrigts, D, Awwad, M, White-Scharf, M, Sachs, D.H, Cooper, D.K.C ^*

Publikováno v: In Transplantation Proceedings 2000 32(5):1009-1009

One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspective.

Autor: Dal Negro G; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom., Eskes C; SeCAM Services and Consultation on Alternative Methods, Via Campagnora 1, 6983, Magliaso, Switzerland. Electronic address: chantra.eskes@secam-ce.eu., Belz S; European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy., Bertein C; A.I.S.E, Boulevard du Souverain 164, 1160, Brussels, Belgium., Chlebus M; European Federation of Pharmaceutical Industries and Associations (EFPIA), Rue du Trône 108, 1050, Brussels, Belgium., Corvaro M; ECPA - the European Crop Protection Association, 6 Avenue E. Van Nieuwenhuyse, 1160, Brussels, Belgium., Corvi R; European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy., Dhalluin S; L'Oréal Research & Innovation, 9 rue Pierre Dreyfus, 92110, Clichy, France., Halder M; European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy., Harvey J; GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, United Kingdom., Hermann M; Henkel AG & Co. KGaA, Henkelstr. 67, 40589, Duesseldorf, Germany., Hoffmann-Dörr S; Henkel AG & Co. KGaA, Henkelstr. 67, 40589, Duesseldorf, Germany., Kilian K; European Commission, Directorate General for the Environment (DG ENV), Brussels, Belgium., Lambrigts D; GlaxoSmithKline Vaccines, 20 Avenue Fleming, 1300, Wavre, Belgium., Laroche C; European Partnership for Alternative Approaches to Animal Testing (EPAA), Av. Herrmann-Debroux 40, 1160, Brussels, Belgium., Louhimies S; European Commission, Directorate General for the Environment (DG ENV), Brussels, Belgium., Mahony C; The Procter & Gamble Company, Whitehall Lane, Egham, Surrey TW20 9NW, United Kingdom., Manou I; European Partnership for Alternative Approaches to Animal Testing (EPAA), Av. Herrmann-Debroux 40, 1160, Brussels, Belgium., McNamee P; The Procter & Gamble Company, Whitehall Lane, Egham, Surrey TW20 9NW, United Kingdom., Prieto P; European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy., Reid K; European Federation of Pharmaceutical Industries and Associations (EFPIA), Rue du Trône 108, 1050, Brussels, Belgium., Roggen E; 3Rs Management and Consulting, Asavænget 14, 2800, Kongens Lyngby, Denmark., Schutte K; European Commission, Directorate General for the Environment (DG ENV), Brussels, Belgium., Stirling C; Zoetis Ltd, Kent, United Kingdom., Uhlrich S; Sanofi Pasteur, 1541 Av. Marcel Merieux, 69280, Marcy l'Etoile, France., Weissenhorn R; European Commission, Directorate General for Internal Market, Industry, Enterpreneurship and SME, Brussels, Belgium., Whelan M; European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21017, Ispra, Italy.

Publikováno v: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2018 Nov; Vol. 99, pp. 33-49. Date of Electronic Publication: 2018 Aug 08.

The vaccines consistency approach project: an EPAA initiative.

Autor: De Mattia, F., Hendriksen, C., Buchheit, K. H., Chapsal, J. M., Halder, M., Lambrigts, D., Redhead, K., Rommel, E., Scharton-Kersten, T., Sesardic, T., Viviani, L., Ragan, I.

Publikováno v: Pharmeuropa Bio & Scientific Notes; 2015, p30-56, 27p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.